Intelligent Bio Solutions Inc. (INBS)
NASDAQ: INBS · Real-Time Price · USD
1.290
-0.010 (-0.77%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Intelligent Bio Solutions Revenue
Intelligent Bio Solutions had revenue of $607.49K in the quarter ending December 31, 2024, a decrease of -20.49%. This brings the company's revenue in the last twelve months to $3.03M, up 23.21% year-over-year. In the fiscal year ending June 30, 2024, Intelligent Bio Solutions had annual revenue of $3.11M with 147.58% growth.
Revenue (ttm)
$3.03M
Revenue Growth
+23.21%
P/S Ratio
1.46
Revenue / Employee
$60,628
Employees
50
Market Cap
8.74M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.90B |
INBS News
- 4 days ago - Intelligent Bio Solutions Expands Global Reach with Latin American Spanish Language Integration into Drug Screening System - GlobeNewsWire
- 26 days ago - Intelligent Bio Solutions Expands Middle East Market Reach with Arabic Integration in Drug Screening System - GlobeNewsWire
- 4 weeks ago - Intelligent Bio Solutions to Highlight Proprietary Drug Testing Technology at 2025 NDASA Conference and Trade Show - GlobeNewsWire
- 4 weeks ago - Intelligent Bio Solutions Highlights Continued Expansion with Strategic Partnership in Spain and Andorra - GlobeNewsWire
- 4 weeks ago - Intelligent Bio Solutions Secures Key U.S. Patent, Strengthening IP Protection Ahead of Planned 2025 Market Entry - GlobeNewsWire
- 4 weeks ago - Intelligent Bio Solutions' FDA Clearance Process Remains on Track for 2025 U.S. Launch - GlobeNewsWire
- 5 weeks ago - Intelligent Bio Solutions to Expand U.S. IP Portfolio with Expected Patent Grant - GlobeNewsWire
- 6 weeks ago - Intelligent Bio Solutions to Participate in the iAccess Virtual Best Ideas Spring Conference on March 25th and 26th - GlobeNewsWire